Kevin Eastwood Executive VP, Corporate Business Development
Stephen Mullennix CFO
Company Description
Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and cereblon IMiDs.